Neuroimaging webinar series by NEuATRIS and EATRIS
EATRIS and NeurATRIS are launching a series of webinars on Neuroimaging in November 2018 (November 6th, 20th, and 27th). The series will cover the usage of CEST-MRI, optical imaging and PET imaging in neurodegenerative diseases and their potential application in translational medicine. All webinars will take place from 14:00-15:00 CET, are free of charge, and include an audience Q&A session. They will be recorded and available for later viewing. More information and registration at this link.
Schedule
SESSION 1: NOVEMBER 6TH 14.00 – 15.00 (CET)
Translational Metabolic Imaging using CEST MRI in Neurodegenerative Diseases by Dr. Julien Flament
Chemical Exchange Saturation Transfer (CEST) imaging has emerged over the past decade as a new and innovative MRI contrast method, specifically designed for molecular imaging. CEST offers the possibility to detect a large variety of metabolites including glutamate, glucose, or creatine. This confers to CEST the potential to provide valuable clues about various pathological features in a single experiment.
SESSION 2: NOVEMBER 20TH 14.00 – 15.00 (CET)
Optical imaging tools for brain cells by Basile Gurchenkov
In this webinar, Basile Gurchenkov will address how to choose the most suitable type of microscope for your neurological mechanisms and cells of interest. He will share his insights about multiphotonic, light-sheet, confocal, transmission electron microscopes and spinning disks.
SESSION 3: NOVEMBER 27TH 14.00 – 15.00 (CET)
PET imaging to investigate neurodegenerative diseases by Sonia Lavisse and Nadja van Camp
Accurate and prompt diagnosis is vital to accommodate differential prognostic and brain disease management approaches, and to assess the efficacy of experimental therapeutic interventions in clinical trials. PET imaging plays a pivotal role in this regard by providing an in vivo opportunity to visualize the neuroanatomical and functional signatures of these disorders, as well as identifying disease-specific biomarkers of the underlying neurodegenerative processes.
This presentation will provide a brief introduction of the PET modality followed by an overview of the prominent preclinical and clinical application of this well-established and promising imaging tool in neurodegenerative diseases.